3 Oral: Tucatinib and Trastuzumab for Patients With Previously Treated, HER2- Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
Titel:
3 Oral: Tucatinib and Trastuzumab for Patients With Previously Treated, HER2- Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
Auteur:
Nakamura, Y. Bekaii-Saab, T. Hamilton, E. Hayashi, H. Mizuno, N. Monk, B.J. Nguyen, D. Okines, A. O’Malley, D.M. Pohlmann, P.R. Pothuri, B. Reck, M. Sudo, K. Sunakawa, Y. Takahashi, S. Yu, E.Y. Drees, A. Tan, S. Stinchcombe, T.E.